SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Nagata, H. Articles by Shimizu, N. Search for Related Content PubMed PubMed Citation Articles by Nagata, H. Articles by Shimizu, N. Related Collections Immunobiology Neoplasia Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 February 2001, Vol. 97, No. 3, pp. 708-713 NEOPLASIA Characterization of novel natural killer (NK)-cell and T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus Hiroshi Nagata, Akiyoshi Konno, Nobuhiro Kimura, Yu Zhang, Michiko Kimura, Ayako Demachi, Teruaki Sekine, Kohtaro Yamamoto, and Norio Shimizu From the Department of Otorhinolaryngology, School of Medicine, Chiba University, Chiba; First Department of Internal Medicine, School of Medicine, Fukuoka University, Fukuoka; and Department of Virology, Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.     Abstract Top Abstract Introduction Patients, materials, and... Results Discussion References Studies on nasal T/natural killer (NK)-cell lymphoma have been hampered by its tendency to cause necrosis. Thus, the establishment of cell lines of this neoplasm would seem to be valuable. This study attempted to establish cell lines from primary lesions of this tumor, and successfully obtained 2 novel Epstein-Barr virus (EBV)-positive cell lines, SNK-6 and SNT-8, by means of high-dose recombinant interleukin 2. Flow cytometry showed that SNK-6 had an NK-cell phenotype, CD3CD4CD8CD19CD56+ T-cell receptor (TCR) / TCR /, whereas SNT-8 was CD3+CD4CD8CD19CD56+ TCR / TCR /+. These were consistent with immunophenotypes of their original tumors, and the cell lines had monoclonal EBV clones identical to ones in their original tumors. Thus, the cell lines developed from cells forming the primary lesions. Genotypic analysis showed that SNK-6 had unrearranged TCR and immunoglobulin heavy-chain genes, supporting the conclusion that SNK-6 was of NK-cell lineage. On the other hand, SNT-8 had rearranged TCR -, -, and -chain genes, and together with its phenotype, SNT-8 proved to be a T-cell line. This is the first report of the establishment of cell lines from primary lesions of nasal T/NK cell lymphomas, and the results demonstrated that there are at least 2 lineages, NK- and T-cell, in this neoplasm. Moreover, it has been suggested that nasal T/NK cell lymphomas of these lineages may belong to the same clinicopathologic entity because both types of cases shared common clinical and histopathologic features. (Blood. 2001;97:708-713) © 2001 by The American Society of Hematology.     Introduction Top Abstract Introduction Patients, materials, and... Results Discussion References Nasal T/natural killer (NK)-cell lymphoma is a distinct clinicopathologic entity characterized by progressive necrotic lesions in the nasal cavity, nasopharynx, and palate.1 It has been called angiocentric lymphoma, lethal midline granuloma, or polymorphic reticulosis.2 It is a relatively rare disease associated with a poor prognosis and more often seen in Asia than in the United States and Europe.3-14 Nasal T/NK-cell lymphomas can exhibit a broad histologic spectrum and usually show invasion of the vascular walls, which is associated with prominent ischemic necrosis of both tumor cells and normal tissue. The most characteristic feature of the disease is a consistent and strong association with the Epstein-Barr virus (EBV); indeed, almost all cases are positive for EBV irrespective of ethnic difference,15-22 yet the precise role of the virus in the etiology of the disease is poorly understood. The cellular origin of the nasal T/NK-cell lymphoma has been controversial. It was initially thought to originate from the T-cell lineage based on immunophenotype.23-27 Later studies using combined immunophenotypic and genotypic analysis have suggested that most nasal T/NK-cell lymphomas are of NK-cell lineage, being CD56+, negative for surface CD3 (Leu4), and unassociated with rearrangements of the T-cell receptor (TCR) genes.11,28-30 On the other hand, some studies have reported the existence of T-cell lymphomas that express TCR proteins, that is / and / chains, associated with rearranged TCR genes; these were presumably T-cell lymphomas10,30 and T-cell lymphomas.18,31 In addition, there have been reports of atypical cases in which cell surface antigens were expressed discordantly; these were CD3(Leu4)+CD56+ cases without TCR gene rearrangements,32 and cases with TCR proteins expressed discordantly with their rearrangement status of the TCR genes.10,29,30 Moreover, it has recently been suggested that nasal T/NK-cell lymphomas of NK- and T-cell lineages are derived from activated cytotoxic cells, have common clinical and histopathologic features, and belong to the same clinicopathologic entity.31 Therefore, precise phenotypes of this neoplasm including the T-cell subset in cases of T-cell lymphomas and their relationships to clinicopathologic features need to be studied. However, it is often difficult to obtain a sufficient amount of tissues from such a necrotic lesion. To solve this problem, the propagation of tumor cells in vitro seems to be useful. Recently, a novel NK-cell line, NK-YS, was established from peripheral blood of a patient with a leukemic-state nasal NK-cell lymphoma.33 However, because nasal T/NK-cell lymphomas infrequently develop leukemia, a more applicable method for establishing a cell line is needed. Therefore, in the present study, we aimed to establish cell lines from primary lesions of nasal T/NK-cell lymphomas. We established 2 novel EBV-positive cell lines of NK- and T-cell lineages, SNK-6 and SNT-8. In the present report, we describe immunologic and molecular biologic features of these cell lines.     Patients, materials, and methods Top Abstract Introduction Patients, materials, and... Results Discussion References Patients and nasal tumors Tumor tissues obtained from 2 Japanese patients with nasal T/NK-cell lymphomas were used in this study. Patient 1 was a 62-year-old man and patient 2 was a 48-year-old woman. Both patients had tumors on their right inferior turbinates through the nasal vestibula. The tumors were composed of granulomatous parts and white necrotic parts (Figure 1). Biopsies were performed at the granulomatous parts, but small necrotic tissues were included. Freshly biopsied tissues were cut into several pieces, and portions of these tissues were used for establishing cell lines. The remaining tissues were fixed in 10% buffered formalin for paraffin sections or frozen in liquid nitrogen for immunophenotyping and molecular analysis. View larger version (58K): [in this window] [in a new window]   Figure 1. Endoscopic findings. The patients' right nasal cavities show granulomatous tumors and white necrosis. Left panel, patient 1; right panel, patient 2. Immunohistochemistry and in situ hybridization Immunophenotyping of cells for B-, T-, and NK-cell differentiation antigens was performed on frozen sections as well as on paraffin sections. The antibodies used for the paraffin sections were anti-CD3 polyclonal antiserum (Dako, Glostrup, Denmark), L26 (anti-CD20, Dako), UCHL-1 (anti-CD45RO, Dako), and anti-CD56 (Novocastra, Newcastle, UK) monoclonal antibodies. The antibodies used for the frozen sections were anti-CD2 (Leu5b) and anti-CD3 (Leu4) monoclonal antibodies (Becton Dickinson, San Jose, CA). A standard peroxidase antiperoxidase complex method followed by diaminobenzidine reaction was used to detect positive signals. Paraffin sections were also used for in situ hybridization with a digoxigenin-labeled oligonucleotide probe complementary to the EBV-encoded RNA (EBER-1): the sequence is 5'-AGACACCGTCCTCACCACCCGGGACTTG TA-3'. Hybridization was detected by the procedure described by Chang and colleagues.34 Cell culture and morphologic evaluation The tumor tissues were minced, and strained through a 70-µm cell strainer (Becton Dickinson). The cells obtained through the strainer were then suspended in RPMI 1640 medium supplemented with antibiotics, 10% heat-inactivated human serum, and 700 U/mL of recombinant human interleukin 2 (IL-2). The cells were cultured in a humidified atmosphere at 37°C with 5% CO2 in air. One half of the medium was exchanged with fresh medium twice a week. The cultured cells from patients 1 and 2 have been maintained in the presence of IL-2 for over 20 months and 17 months, respectively, and designated as SNK-6 and SNT-8. Cytocentrifuge smears of the cells were prepared and stained with May-Giemsa for morphologic evaluation. Flow cytometric analysis The SNK-6 and SNT-8 cells were analyzed by 2-color immunofluorescence with a flow cytometer (EPICS XL, Beckman Coulter, Hialeah, FL) for the expression of surface markers. The following antibodies conjugated with fluorescein isothiocyanate (FITC) or phycoerythrin (PE) (Becton Dickinson) were used: anti-CD3, -CD4, -CD8, -CD16, -CD19, -CD21, -CD25, -CD56, -CD57, -HLA-DR, -TCR /, and -TCR /. Southern blot analysis for TCR and immunoglobulin genes The SNK-6 and SNT-8 cells were analyzed for rearrangements of the TCR , , and  chains and the immunoglobulin heavy-chain genes by Southern blotting. DNA (3 µg) extracted from each of the cell lines was digested with a restriction endonuclease BamHI, EcoRI, or HindIII (TAKARA, Kyoto, Japan), electrophoresed through a 0.7% agarose gel and transferred onto a nylon membrane. Human placenta DNA was used as a germline control. The membrane was subjected to a fluorescein-labeled C1, J1, J1, or J3 probe for the TCR genes, or a JH probe for the immunoglobulin heavy-chain gene.35-39 The J3 probe was a 1.5-kb XbaI genomic fragment of the J3 region. In addition, DNA was digested with KpnI for the J1 probe, and processed in the same manner. Hybridizations were visualized by a Fluorescein Gene Images System (Amersham, Buckinghamshire, UK) according to the manufacturer's instructions. Assessment of clonality of EBV DNA extracted from the cell lines as well as the frozen tumor tissues were digested with BamHI, separated on a 0.7% agarose gel, and transferred to a nylon membrane. A 1.9-kb XhoI subfragment of BamHI-Dhet derived from EBV termini was used as a probe for terminal repeats of the EBV DNA40 according to the methods for detecting signals described above. Raji and B95-8 cells were used as controls for cell expansion with monoclonal EBV infection and polyclonal EBV replication, respectively.     Results Top Abstract Introduction Patients, materials, and... Results Discussion References Primary lesions The tumors in both patients shared common histologic features. The normal structure of the nasal mucosa disappeared and was replaced by tumors, and nonsuppurative necrosis was readily noted. The tumors were composed of pleomorphic, medium- to large-sized atypical lymphoid cells. Infiltration of neoplastic cells to small vessels was observed (Figure 2). In situ hybridization showed that both tumors were positive for EBV. Immunophenotypes of both tumors were CD3+ CD20CD56+, whereas the tumors showed a difference in positivity for the surface CD3 (Leu4) antigen. The tumor in patient 1 was CD3 (Leu4), and the tumor in patient 2 was CD3 (Leu4)+. These results indicated that the tumor in patient 1 had a phenotype of NK cells. The results are summarized in Table 1. View larger version (73K): [in this window] [in a new window]   Figure 2. Histopathology. Primary lesions show invasion of tumor cells to small blood vessels. (A) Patient 1. (B) Patient 2. (Hematoxylin-eosin, final magnification × 140).                                View this table: [in this window] [in a new window]   Table 1. Summary of phenotypes of primary tumors Morphology and phenotypes of the cell lines The morphologies of the SNK-6 and SNT-8 cells were similar to each other, except for their sizes. The SNK-6 cells were composed of medium to large cells, whereas the SNK-8 cells included small cells as well as medium to large ones (Figure 3). Large cells in both cell lines had large nuclei and abundant basophilic cytoplasm. Nuclei as well as cytoplasm became smaller and pycnotic as the cell sizes became smaller. Both cells had a number of cytoplasmic vacuoles, but scarcely any azurophilic granules. View larger version (62K): [in this window] [in a new window]   Figure 3. Morphology. Established cell lines show rich cytoplasmic vacuoles and no azurophilic granules. (A) SNK-6. (B) SNT-8. (Wright-Giemsa, final magnification × 440) Flow cytometry showed that the SNK-6 cells were CD3 CD4CD8CD16CD19CD21CD25+CD56+CD57HLA-DR+, and TCR / TCR / (Figure 4A). Thus, SNK-6 was shown to have an NK-cell phenotype. On the other hand, the SNK-8 cells were CD3+CD4CD8CD16CD19CD21CD25+CD56+CD57HLA-DR+, and TCR / TCR /+ (Figure 4B). View larger version (28K): [in this window] [in a new window]   Figure 4. Expression of cell surface markers for subset of T cells and NK cells by established cell lines. (A) SNK-6. (B) SNT-8. Southern blot analysis for TCR and immunoglobulin genes Neither of the cell lines showed a rearrangement of the immunoglobulin heavy-chain gene. In terms of the TCR genes, the SNK-6 cells showed no rearrangements of the TCR -, -, and -chain genes, supporting that SNK-6 is of NK-cell lineage (Figure 5). On the other hand, the SNT-8 cells showed rearrangements of the -, -, and -chain genes. The rearrangements of the -chain gene were initially not detected by the J1 probe hybridized with BamHI, EcoRI, or HindIII digest (Figure 5B). Then, we evaluated hybridization of the probe with the KpnI digest, because it has been reported that the V9-JP rearrangement frequently observed in rearranging  loci can be detected with the KpnI digest, but the BamHI rearranged band has virtually the same size as the germline bands and the EcoRI and HindIII bands are in germline configuration in this rearrangement.41,42 As expected, a 9-kb germline band derived from a KpnI fragment including the JP gene changed to a 12-kb band probably by assignment of the V9 gene to the JP gene (Figure 5B). With respect to the -chain gene, deletion was initially found in the J1 region in the SNT-8 cells (Figure 5C), suggesting that rearrangements of the -chain gene or deletion of the -chain gene occurred in the cells.43 Subsequently, we sought rearrangements of the -chain gene by hybridizing the blots with the J3 probe, because the SNT-8 cells showed expression of the TCR / receptor by flow cytometry. As a result, the J3 probe successfully detected rearranged bands, indicating that the deletion of the J1 gene was a consequence of the usage of the J3 gene in rearrangements of the  locus. (Figure 5D). View larger version (87K): [in this window] [in a new window]   Figure 5. Southern blot analysis. Southern blot analysis shows no rearrangements of TCR genes in SNK-6 and rearrangements of the -, -, and -chain genes in SNT-8. Panels show hybridization with the following probes: (A) the C1 probe, (B) the J1 probe, (C) the J1 probe, (D) the J3 probe. Human placenta DNA was used as a germline control. The letters above the pictures are BamHI (B), EcoRI (E), HindIII (H), and KpnI (K) digest. Note that the rearrangements of the -chain gene in SNT-8 cannot be detected by the BamHI, EcoRI, or HindIII digest. The lack of a 5-kb HindIII band hybridizing with the J1 probe in SNT-8 is due to a polymorphism for a HindIII cleavage site.41 Clonality of EBV Southern blot analysis for the number of EBV terminal repeats showed a monoclonal band in each of the SNK-6 cells, the SNT-8 cells, and their original tumors. In addition, the bands in the cell lines corresponded to the bands in their respective original tumors (Figure 6). View larger version (133K): [in this window] [in a new window]   Figure 6. Clonality of EBV. Southern blot analysis for clonality of EBV as evidence for monoclonal expansions of EBV-positive cells in primary tumor in patient 1 (lane 1), SNK-6 cells (lane 2), primary tumor in patient 2 (lane 3), and SNT-8 cells (lane 4). Controls are B95-8 cells (B) and Raji cells (R) for cells with monoclonal EBV expansion and polyclonal EBV replication, respectively.     Discussion Top Abstract Introduction Patients, materials, and... Results Discussion References The present study established 2 novel cell lines of T/NK-cell lineage from the primary lesions of nasal T/NK-cell lymphomas by means of a simple technique using high-dose IL-2. Established cell lines had monoclonal EBV clones identical to those in their respective original lesions. Moreover, the flow cytometric phenotypes of the cell lines corresponded with the immunohistochemical phenotypes of the primary lesions. Therefore, the cell lines were demonstrated to have developed from cells that formed the nasal T/NK-cell lymphomas in the patients. As far as we know, this is the first report describing the establishment of cell lines from primary lesions of the nasal T/NK-cell lymphoma. The establishment of tumor cell lines seems to be valuable for the study of the nasal T/NK-cell lymphoma because the tendency of the disease to cause necrosis has hampered detailed analyses of the tumor. Recently, a novel NK-cell line NK-YS was established from the peripheral blood of a patient with a leukemic-state nasal NK-cell lymphoma.33 However, an association of leukemia with this disease is not common. Thus, we believe that a technique to establish a cell line from a primary lesion is more applicable to the disease. We have tried to date to establish cell lines from 5 primary lesions obtained from 5 independent patients and have succeeded in obtaining the 2 cell lines and in maintaining 2 other cells for over 1 month. Therefore, we believe that the technique described here will be generally useful for establishing cell lines from more cases of nasal T/NK-cell lymphomas. The establishment of tumor cell lines appears to have advantages over biopsies for phenotypic and genotypic studies. In phenotypic studies, the expression of cell surface antigens can be analyzed more accurately by flow cytometry for suspended cells than by immunohistochemistry on tissue sections because most monoclonal antibodies for cell surface antigens were originally developed for flow cytometry, and the results of immunohistochemistry are occasionally difficult to interpret. Moreover, a cytoplasmic molecule such as CD3 in NK cells, which is not expressed on the cell surface,30,44,45 may lead to false-positive results by immunohistochemistry, and can be assessed accurately by flow cytometry. With respect to genotypic studies, propagation of a clonal population of tumor cells appears to generate a clear result, whereas analysis of a biopsied tissue is associated with potentially equivocal findings because of the presence of nontumorous cells.46 Furthermore, the availability of a large amount of DNA allows us to repeat analysis and to try various DNA probes to confirm the reproducibility of our results. In the present study, the results of phenotypic and genotypic analysis completely agreed with each other in the SNK-6 cells. The SNK-6 cells had an NK-cell phenotype CD3(Leu4)CD4 CD8CD19CD56+TCR / TCR / and unrearranged TCR genes. On the other hand, the SNT-8 cells had a T-cell phenotype CD3(Leu4)+CD4CD8CD19TCR / TCR /+ and showed rearrangements of the - and the -chain genes of the TCR, yet it was also CD56+ and associated with a rearranged -chain gene. Because it was reported that peripheral T-cell lymphomas frequently expressed CD5631,47-49 and showed rearrangements of the -chain gene,47,49,50 SNT-8 was considered to be a tumor cell line of T-cell lineage. Hence, the nasal T/NK-cell lymphoma in case 2 proved to be a T-cell lymphoma. On the basis of previous reports, NK-cell is the predominant phenotype in nasal T/NK-cell lymphomas, and T cell is a minor phenotype.11,18,28,30,32 Therefore, SNT-8 should be useful for the study on the nasal T/NK-cell lymphoma of the T-cell subset. The genotypic studies of the SNT-8 cells gave us 2 lessons in evaluating rearrangements of the TCR genes in T-cell lymphomas. First, for analysis of the TCR -chain gene by using the J1 probe, KpnI digest should be analyzed, when BamHI, EcoRI, or HindIII digest does not show a rearrangement.41,42 Second, when no signal is detected by the J1 probe, another probe for the -chain gene should be applied to determine whether it is deleted or rearranged.39,43 However, to determine the subset of T-cell lymphomas, expression of the / or / TCR should be confirmed, because rearrangements of the -chain gene are commonly found in T-cell lymphomas irrespective of the type of TCR that is expressed51 and rearrangements of the -chain gene are also found in T-cell lymphomas as described above. In addition, consistency between the genotype and the phenotype seems necessary. Reviewing previously reported cases with nasal T-cell lymphomas with these considerations, we found only a small number of cases that can be clearly categorized as or T-cell lymphoma. Two of the 4 cases with nasal T-cell lymphomas reported by Chiang and coworkers29,30 (case 2 in reference 29 and case 9 in reference 30), a case in a series of 10 cases of T-cell lymphomas by Harabuchi and colleagues10 (case 17), and a CD3+ TCR /+ sinonasal case by Kanavaros and associates12 appeared to be T-cell lymphomas. Interestingly, in contrast to most T-cell lymphomas, 3 of these 4 cases were negative for CD56 and the other one was only weakly positive for CD56. On the other hand, one T-cell case was reported by Kanavaros and coworkers,18 and 2 more cases were recently reported by the same group.31 Independently, 7 cases of possible T-cell lymphomas were reported by Harabuchi and colleages10; these cases were positive for the -chain protein and negative for the -chain protein, whereas 2 of them were CD3, and none of them showed simultaneous rearrangements of the - and -chain genes. In addition, our case 2 was a T-cell lymphoma. Therefore, it may be that the T-cell subset is relatively common in the nasal T-cell lymphoma. The establishment of more cell lines appears to contribute to clarifying the features of the subset of the nasal T-cell lymphoma. In the present study, the NK- and the T-cell lymphomas formed similar tumors characterized by granulomatous appearance and necrosis in the nasal mucosa. Moreover, both tumors consisted of pleomorphic medium- to large-sized cells, which showed angioinvasion and were positive for EBV and CD56+. Recently, Arnulf and coworkers studied 11 cases of nonhepatosplenic peripheral T-cell lymphomas31; 3 of these cases presented in the nasal cavity and the other cases were in other extranodal sites, including the larynx, lung, gastrointestinal tract, or skin. Interestingly, all of the 3 nasal cases were EBV positive, and 2 of them were CD56+, whereas only a few cases in the other sites were EBV positive, and none of them was CD56+. They concluded that nasal T/NK-cell lymphomas, whatever their NK- or T-cell origin, have common clinical and histopathologic features, are associated with EBV, and are derived from activated cytotoxic cells, and thus most likely belong to the same clinicopathologic entity. The present results appear to support their conclusions. Although the etiology of the nasal T/NK-cell lymphoma is largely unknown, it has been recognized that the disease occurs in a consistent and strong association with EBV.15-22 Likewise, SNK 6 and SNT-8 harbored monoclonal EBV clones. However, the mechanisms by which T/NK cell lineages are affected by the virus are poorly understood. In terms of the infecting route, CD21 is the only known receptor for the virus to date.52,53 Kaneko and colleagues showed that CD21 was expressed on normal NK cells activated with IL-2 as well as on isolated tumor cells from a nasal NK-cell lymphoma.54 However, 2 EBV-positive NK-cell lines, SNK-6 in the present study and NK-YS,33 did not express the CD21 antigen. Likewise, 5 EBV-positive T-cell lines, SNT-8 in the present study and 4 cell lines reported previously,55 were negative for the CD21 antigen. With respect to the tumorigenicity of the virus, the latent membrane protein LMP-1 is known to possess transforming activity for rodent as well as human cells,56,57 and may also play a role in the nasal T/NK-cell lymphoma. Cytogenetic studies have shown frequent abnormalities in chromosome 6 in nasal T/NK-cell lymphomas,58,59 and there has also been a report that abnormalities of chromosome 6 were additionally recognized in cells isolated from patients with chronic active EBV infection and that the abnormalities might be caused by the integration of the virus to chromosome 6.60 Therefore, to clarify a role of the EBV in the etiology of the nasal T/NK-cell lymphoma, virologic, molecular biologic, and cytogenetic studies seem to be necessary, warranting the use of the established cell lines for future studies and necessitating further efforts to develop more cell lines from nasal T/NK-cell lymphomas.     Acknowledgment The authors thank Mrs Aya Kasuya for her technical assistance.     Footnotes Submitted May 30, 2000; accepted September 1, 2000. Supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (no. 11670207 and 09253103) and Grants-in-Aid for Education and Research Promotion Program 1999 from Tokyo Medical and Dental University. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Norio Shimizu, Department of Virology, Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan; e-mail: nshivir{at}mri.tmd.ac.jp.     References Top Abstract Introduction Patients, materials, and... Results Discussion References 1. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111[CrossRef][Medline] [Order article via Infotrieve]. 2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392[Free Full Text]. 3. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood. 1988;72:1674-1681[Abstract/Free Full Text]. 4. Weiss LM, Picker LJ, Grogan TM, Warnke RA, Sklar J. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol. 1988;130:436-442[Abstract]. 5. Frierson HF, Innis DJ, Mills SE, Wick MR. Immunophenotypic analysis of sinonasal non-Hodgkin's lymphomas. Hum Pathol. 1989;20:636-642[CrossRef][Medline] [Order article via Infotrieve]. 6. Aozasa K, Ohsawa M, Tajima K, et al. Nation-wide study of lethal midline granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer. 1989;44:63-66[Medline] [Order article via Infotrieve]. 7. Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol. 1990;21:1041-1050[CrossRef][Medline] [Order article via Infotrieve]. 8. Ratech H, Burke JS, Blayney DW, et al. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses, and hard palate, including cases of lethal midline granuloma. Cancer. 1989;64:2525-2531[CrossRef][Medline] [Order article via Infotrieve]. 9. Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol. 1991;15:268-279[Medline] [Order article via Infotrieve]. 10. Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer. 1996;77:2137-2149[CrossRef][Medline] [Order article via Infotrieve]. 11. Emile J-F, Boulland M-L, Haioun C, et al. CD5 CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87:1466-1473[Abstract/Free Full Text]. 12. Kanavaros P, Briere J, Lescs M-C, Gaulard P. Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells. J Pathol. 1996;178:297-302[CrossRef][Medline] [Order article via Infotrieve]. 13. Nakamura S, Katoh E, Koshikawa T, et al. Clinicopathologic study of nasal T/NK cell lymphoma among the Japanese. Pathol Int. 1997;47:38-53[Medline] [Order article via Infotrieve]. 14. Cheung MMC, Chan JKC, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70-77[Abstract/Free Full Text]. 15. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 1990;335:128-130[CrossRef][Medline] [Order article via Infotrieve]. 16. Ho FCS, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol. 1990;8:271-281[Medline] [Order article via Infotrieve]. 17. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol. 1992;16:156-162[Medline] [Order article via Infotrieve]. 18. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81:2688-2695[Abstract/Free Full Text]. 19. Borisch B, Hennig I, Laeng RH, Waelti ER, Kraft R, Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood. 1993;82:858-864[Abstract/Free Full Text]. 20. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 1993;17:392-399[CrossRef][Medline] [Order article via Infotrieve]. 21. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr viral RNA in malignant lymphoma of the upper aerodigestive tract. Am J Surg Pathol. 1994;18:938-946[Medline] [Order article via Infotrieve]. 22. Gorp JV, Weiping L, Jacobse K, et al. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J Pathol. 1994;173:81-87[CrossRef][Medline] [Order article via Infotrieve]. 23. Ishii Y, Yamanaka N, Ogawa K, et al. Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma." Cancer. 1982;50:2336-2344[CrossRef][Medline] [Order article via Infotrieve]. 24. Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. 1984;2:413-426[Medline] [Order article via Infotrieve]. 25. Yamanaka N, Harabuchi Y, Sambe S, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Cancer. 1985;56:768-776[CrossRef][Medline] [Order article via Infotrieve]. 26. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol. 1987;11:418-429[Medline] [Order article via Infotrieve]. 27. Lippman SM, Grogan TM, Spier CM, et al. Lethal midline granuloma with novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer. 1987;59:936-939[CrossRef][Medline] [Order article via Infotrieve]. 28. Petrella T, Delfau-Larue M-H, Caillot D, et al. Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol. 1996;27:827-833[CrossRef][Medline] [Order article via Infotrieve]. 29. Chiang AKS, Srivastava G, Lau PWF, Ho FCS. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin. Hum Pathol. 1996;27:701-707[CrossRef][Medline] [Order article via Infotrieve]. 30. Chiang AKS, Chan ACL, Srivastava G, Ho FCS. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer. 1997;73:332-338[CrossRef][Medline] [Order article via Infotrieve]. 31. Arnulf B, Copie-Bergman C, Delfau-Larue M-H, et al. Nonhepatosplenic T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91:1723-1731[Abstract/Free Full Text]. 32. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood. 1994;83:2255-2260[Abstract/Free Full Text]. 33. Tsuchiyama J, Yoshino T, Mori M, et al. Characterization of a novel natural killer-cell line (NK-YS) established from natural killer cell/lymphoma leukemia associated with Epstein-Barr virus infection. Blood. 1998;92:1374-1383[Abstract/Free Full Text]. 34. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255[Medline] [Order article via Infotrieve]. 35. Sims JE, Tunnacliffe A, Smith WJ, Rabbitts TH. Complexity of human T-cell antigen receptor -chain constant- and variable-region gene. Nature. 1984;312:541-545[CrossRef][Medline] [Order article via Infotrieve]. 36. Quertermouse T, Murre C, Dialynas D, et al. Human T-cell  chain genes: organization, diversity, and rearrangement. Science. 1986;231:252-255[Abstract/Free Full Text]. 37. Tkachuk DC, Griesser H, Takihara Y, et al. Rearrangement of T-cell  locus in lymphoproliferative disorders. Blood. 1988;72:353-357[Abstract/Free Full Text]. 38. Korsmeyer SJ, Arnold A, Bakhshi A, et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 1983;71:301-313. 39. Takihara Y, Tkachuk D, Michalopoulos E, et al. Sequence and organization of the diversity, joining, and constant region genes of the human T-cell -chain locus. Proc Natl Acad Sci U S A. 1988;85:6097-6101[Abstract/Free Full Text]. 40. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986;47:883-889[CrossRef][Medline] [Order article via Infotrieve]. 41. Huck S, Lefranc M-P. Rearrangements to the JP1, JP, and JP2 segments in the human T-cell rearranging gamma gene (TRG) locus. FEBS Lett. 1987;224:291-296[CrossRef][Medline] [Order article via Infotrieve]. 42. Triebel F, Faure F, Graziani M, et al. A unique V-J-C-rearranged gene encodes a protein expressed on the majority of CD3+ T cell receptor-/ circulating lymphocytes. J Exp Med. 1988;167:694-699[Abstract/Free Full Text]. 43. Chien Y, Iwashima M, Kaplan K, Elliott J, Davis M. A new T cell receptor gene located within the alpha locus and expressed early in T cell differentiation. Nature. 1987;327:677-682[CrossRef][Medline] [Order article via Infotrieve]. 44. Lanier LL, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3 proteins in activated human adult natural killer (NK) cells and CD3, ,  complexes in fetal NK cells. J Immunol. 1992;149:1876-1880[Abstract]. 45. Chan JKC, Tsang WYW, Ng FCS, Pau MY. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol. 1995;26:1139-1143[CrossRef][Medline] [Order article via Infotrieve]. 46. Cossman J, Zehnbauer B, Garrett CT, et al. Gene rearrangements in the diagnosis of lymphoma/leukemia: guidelines for use based on a multiinstitutional study. Am J Clin Pathol. 1991;95:347-354[Medline] [Order article via Infotrieve]. 47. Wong KF, Chan JKC, Matutes E, et al. Hepatosplenic T-cell lymphoma: a distinctive aggressive lymphoma type. Am J Surg Pathol. 1995;19:718-726[Medline] [Order article via Infotrieve]. 48. Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic T-cell origin. Blood. 1996;88:4265-4274[Abstract/Free Full Text]. 49. Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas: identification of a subset of / T-cell lymphomas. Am J Pathol. 1990;137:617-628[Abstract]. 50. Mastovich S, Ratech H, Ware R, Moore JO, Borowits MJ. Hepatosplenic T-cell lymphoma: an unusual case of a T-cell lymphoma with a blast-like terminal transformation. Hum Pathol. 1994;25:102-108[CrossRef][Medline] [Order article via Infotrieve]. 51. Medeiros LJ, Bagg A, Cossman J. Molecular genetics in the diagnosis and classification of lymphoid neoplasms. In: Jaffe ES, ed. Surgical Pathology of the Lymph Nodes and Related Organs: Major Problems in Pathology. Vol 16. Philadelphia: Saunders; 1995:58-97. 52. Moore MD, Cooper NR, Tack BF, Nemerow G. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci U S A. 1987;84:9194-9198[Abstract/Free Full Text]. 53. Tanner J, Weis J, Fearon D, Whang Y, Kieff E. Epstein-Barr virus gp350/220 binding to the B lymphocytes C3d receptor mediates adsorption, capping, and endocytosis. Cell. 1987;50:203-213[CrossRef][Medline] [Order article via Infotrieve]. 54. Kaneko T, Fukuda J, Yoshihara T, et al. Natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br J Haematol. 1995;91:355-361[Medline] [Order article via Infotrieve]. 55. Imai S, Sugiura M, Oikawa O, et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood. 1996;87:1446-1457[Abstract/Free Full Text]. 56. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985;43:831-840[CrossRef][Medline] [Order article via Infotrieve]. 57. Fahraeus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 1990;345:447-449[CrossRef][Medline] [Order article via Infotrieve]. 58. Tien H-F, Su I-J, Tang J-L, et al. Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. Br J Haematol. 1997;97:621-625[CrossRef][Medline] [Order article via Infotrieve]. 59. Wong KF, Chan JKC, Kwong YL. Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukemia. Br J Haematol. 1997;98:922-926[CrossRef][Medline] [Order article via Infotrieve]. 60. Ohshima K, Suzumiya J, Ohga S, Ohgami A, Kikuchi M. Integrated Epstein-Barr virus (EBV) and chromosomal abnormality in chronic active EBV infection. Int J Cancer. 1997;71:943-947[CrossRef][Medline] [Order article via Infotrieve]. © 2001 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: L. Shen, W.-Y. Au, K.-Y. Wong, N. Shimizu, J. Tsuchiyama, Y.-L. Kwong, R. H. Liang, and G. Srivastava Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells Mol. Cancer Ther., December 1, 2008; 7(12): 3807 - 3815. [Abstract] [Full Text] [PDF] H. Kobayashi, T. Nagato, M. Takahara, K. Sato, S. Kimura, N. Aoki, M. Azumi, M. Tateno, Y. Harabuchi, and E. Celis Induction of EBV-Latent Membrane Protein 1-Specific MHC Class II-Restricted T-Cell Responses against Natural Killer Lymphoma Cells Cancer Res., February 1, 2008; 68(3): 901 - 908. [Abstract] [Full Text] [PDF] L. L. Kis, M. Takahara, N. Nagy, G. Klein, and E. Klein IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines Blood, April 1, 2006; 107(7): 2928 - 2935. [Abstract] [Full Text] [PDF] T. Nagato, H. Kobayashi, K. Kishibe, M. Takahara, T. Ogino, H. Ishii, K. Oikawa, N. Aoki, K. Sato, S. Kimura, et al. Expression of Interleukin-9 in Nasal Natural Killer/T-Cell Lymphoma Cell Lines and Patients Clin. Cancer Res., December 1, 2005; 11(23): 8250 - 8257. [Abstract] [Full Text] [PDF] M. K. Oyoshi, H. Nagata, N. Kimura, Y. Zhang, A. Demachi, T. Hara, H. Kanegane, Y. Matsuo, T. Yamaguchi, T. Morio, et al. Preferential Expansion of V{gamma}9-J{gamma}P/V{delta}2-J{delta}3 {gamma}{delta} T Cells in Nasal T-Cell Lymphoma and Chronic Active Epstein-Barr Virus Infection Am. J. Pathol., May 1, 2003; 162(5): 1629 - 1638. [Abstract] [Full Text] [PDF] K. Hayashi, Z. Jin, S. Onoda, H. Joko, N. Teramoto, N. Ohara, W. Oda, T. Tanaka, Y.-X. Liu, T. R. Koirala, et al. Rabbit Model for Human EBV-Associated Hemophagocytic Syndrome (HPS): Sequential Autopsy Analysis and Characterization of IL-2-Dependent Cell Lines Established from Herpesvirus Papio-Induced Fatal Rabbit Lymphoproliferative Diseases with HPS Am. J. Pathol., May 1, 2003; 162(5): 1721 - 1736. [Abstract] [Full Text] [PDF] C.-W. Lin, W.-H. Lee, C.-L. Chang, J.-Y. Yang, and S.-M. Hsu Restricted Killer Cell Immunoglobulin-Like Receptor Repertoire without T-Cell Receptor {gamma} Rearrangement Supports a True Natural Killer-Cell Lineage in a Subset of Sinonasal Lymphomas Am. J. Pathol., November 1, 2001; 159(5): 1671 - 1679. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Nagata, H. Articles by Shimizu, N. Search for Related Content PubMed PubMed Citation Articles by Nagata, H. Articles by Shimizu, N. Related Collections Immunobiology Neoplasia Social Bookmarking                   What's this?

	Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020